TOCQUEVILLE ASSET MANAGEMENT L.P. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 214 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$311,823
-15.1%
29,6410.0%0.01%
-14.3%
Q4 2022$367,252
+24.1%
29,641
+3.9%
0.01%
+16.7%
Q3 2022$296,000
-10.0%
28,5310.0%0.01%0.0%
Q2 2022$329,000
-8.4%
28,5310.0%0.01%
+20.0%
Q1 2022$359,000
+7.8%
28,5310.0%0.01%0.0%
Q4 2021$333,000
-10.7%
28,5310.0%0.01%
-16.7%
Q3 2021$373,000
+1.6%
28,5310.0%0.01%
+20.0%
Q2 2021$367,000
+15.0%
28,5310.0%0.01%0.0%
Q1 2021$319,000
-1.8%
28,5310.0%0.01%0.0%
Q4 2020$325,000
+26.5%
28,5310.0%0.01%0.0%
Q3 2020$257,000
-12.6%
28,5310.0%0.01%
-16.7%
Q2 2020$294,000
-45.6%
28,531
-46.7%
0.01%
-53.8%
Q1 2020$540,000
-24.2%
53,5310.0%0.01%
+30.0%
Q4 2019$712,000
+190.6%
53,531
+87.6%
0.01%
+233.3%
Q3 2019$245,000
-21.5%
28,5310.0%0.00%
-25.0%
Q2 2019$312,000
-19.2%
28,5310.0%0.00%
-20.0%
Q1 2019$386,000
+29.5%
28,531
-0.9%
0.01%
+25.0%
Q4 2018$298,000
-44.0%
28,8040.0%0.00%
-42.9%
Q3 2018$532,000
-3.4%
28,8040.0%0.01%0.0%
Q2 2018$551,000
+20.6%
28,804
-2.7%
0.01%
+16.7%
Q1 2018$457,000
+2.9%
29,6120.0%0.01%
+20.0%
Q4 2017$444,000
-4.9%
29,6120.0%0.01%0.0%
Q3 2017$467,000
-16.5%
29,6120.0%0.01%
-28.6%
Q2 2017$559,000
+10.7%
29,6120.0%0.01%
+16.7%
Q1 2017$505,000
+11.5%
29,6120.0%0.01%0.0%
Q4 2016$453,000
-42.5%
29,612
-40.3%
0.01%
-33.3%
Q3 2016$788,000
-39.3%
49,612
-50.0%
0.01%
+12.5%
Q2 2016$1,298,000
+139.0%
99,224
+100.0%
0.01%
+14.3%
Q1 2016$543,000
-5.6%
49,6120.0%0.01%
-12.5%
Q4 2015$575,000
+9.3%
49,612
-1.7%
0.01%
+14.3%
Q3 2015$526,000
-13.6%
50,4950.0%0.01%0.0%
Q2 2015$609,000
-24.6%
50,4950.0%0.01%
-22.2%
Q1 2015$808,000
+4.4%
50,4950.0%0.01%
+12.5%
Q4 2014$774,000
+18.3%
50,4950.0%0.01%
+14.3%
Q3 2014$654,000
-15.5%
50,4950.0%0.01%
-12.5%
Q2 2014$774,000
+24.4%
50,4950.0%0.01%0.0%
Q1 2014$622,000
+4.0%
50,495
-1.9%
0.01%0.0%
Q4 2013$598,000
-2.0%
51,4950.0%0.01%0.0%
Q3 2013$610,000
+19.4%
51,4950.0%0.01%
+14.3%
Q2 2013$511,00051,4950.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders